David E. Johnson
Board Member
Exelixis, Inc. (EXEL)Equibles does not estimate personal net worth.
Get an email with a short summary when Exelixis, Inc. publishes a filing, an earnings call transcript or a press release.
Get EXEL alertsAbout David E. Johnson
David E. Johnson is recorded as Board Member at Exelixis, Inc. (EXEL) since January 1, 2023. The newest filing on record that lists David E. Johnson as Board Member at Exelixis, Inc. (EXEL) is dated April 15, 2026. Exelixis, Inc. reported in an 8-K filed May 29, 2026 a re-election or new board role (Director) for David E. Johnson, on the board since at least 2023, effective May 26, 2026. Exelixis, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Exelixis, Inc. includes Michael M. Morrissey (CEO and Board Member), Michael Morrissey (CEO and Board Member), Christopher Senner (CFO) and 7 others.
“Exelixis stockholders elected the following 11 directors to serve until the next annual meeting of stockholders in 2027, and until his or her successor is elected and qualified, or until his or her earlier death, resignation or removal”
Affiliation history
-
Current
2023-01-01–present
Last confirmed April 15, 2026
Company network
Leadership on record at Exelixis, Inc.
- Michael M. Morrissey CEO, Board Member
- Michael Morrissey CEO, Board Member
- Christopher Senner CFO
- Brenda Hefti, J.D., Ph.D. General Counsel
- Brenda J. Hefti General Counsel
- Alan M. Garber, M.D., Ph.D. Board Member
- Carl B. Feldbaum, Esq. Board Member
- Charles Cohen, Ph.D. Board Member
- George Poste Board Member
- George Poste, DVM, Ph.D., FRS Board Member